ImmuneOnco Biopharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Deals

12 September 2024

One ricochet of the ivonescimab bullet

The small cap biotech Instil Bio tries to follow in Summit’s slipstream.

Subscribe to ImmuneOnco Biopharmaceuticals